El-Khoueiry, Anthony B.; Kim, Richard D.; Harris, William Proctor et al.
Updated results of a phase 1b study of regorafenib (REG) 80 mg/day or 120 mg/day plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC).JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 15. 2021
Neuberger, Elmo W. I.; Brahmer, Alexandra; Ehlert, Tobias et al.
Validating quantitative PCR assays for cfDNA detection without DNA extraction in exercising SLE patientsSCIENTIFIC REPORTS. Bd. 11. H. 1. 2021
Marczynski, Paul; Meineck, Myriam; Xia, Ning et al.
Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease InitiationINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 22. H. 5. 2021
Mohr, A; Bodenstein, M; Sagoschen, I et al.
Verordnung und Applikation von Dauerinfusionen in Standardkonzentrationen bei erwachsenen Intensivpatienten. Ein Meilenstein zur Verbesserung der Arzneimitteltherapiesicherheit.Anästh. Intensivmed. H. 62. 2021 S. 314-322
Nettelbeck, Dirk M.; Leber, Mathias F.; Altomonte, Jennifer et al.
Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical StudiesVIRUSES-BASEL. Bd. 13. H. 8. 2021
Kluge, Stefan; Janssens, Uwe; Welte, Tobias et al.
Webinar on Recommendations for inpatient Treatment of Patients with COVID-19-Living GuidelineCHIRURG. Bd. 92. H. 9. 2021 S. 850-850
Hegewald, Janice; Romero Starke, Karla; Garthus-Niegel, Susan et al.
Work-life conflict and cardiovascular health: 5-year follow-up of the Gutenberg Health StudyPLOS ONE. Bd. 16. H. 5. 2021
Banovcin, Peter; Neumann, Helmut
"Pushing" forward deep bile duct cannulationDIGESTIVE AND LIVER DISEASE. Bd. 52. H. 2. 2020 S. 127-129
Maasberg, Sebastian; Bacher, Maria; Rinke, Anja et al.
"Routine Usage of Molecular Targeted Therapies (Everolimus and Sunitinib) and Temozolomide Based Chemotherapy in Neuroendocrine Neoplasia and Its Outcome"ONCOLOGY RESEARCH AND TREATMENT. Bd. 43. 2020 S. 43-44
Eslam, Mohammed; Newsome, Philip N.; Sarin, Shiv K. et al.
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementJOURNAL OF HEPATOLOGY. Bd. 73. H. 1. 2020 S. 202-209